Select Page
Origin of the theory of autoimmunity in COVID-19 and its implications for therapy and treatment.
  • First documentation of the theory of autoimmunity in COVID-19 in April 2020. 0:27

  • Recent paper highlighting development of ACE2 antibodies after SARS-CoV-2 infection. 1:45

  • Understanding autoimmunity in COVID-19 can lead to life-saving therapies. 2:25

  • Steroids are effective in COVID-19 due to autoimmune response principles. 2:40

  • Autoimmune diseases involve the body attacking normal parts, requiring immune suppression. 3:20

Origin of Autoimmunity Theory in COVID-19 and its Relation to Antibody Levels
  • Autoimmunity theory in COVID-19 originated from the observation of elevated antibody levels in convalescent and inpatient groups. 4:00

  • Outpatients without severe symptoms had lower antibody levels compared to convalescent and inpatient groups. 7:24

  • Research showed that autoantibodies were primarily present in inpatients and convalescent individuals. 7:47

  • A total of 41 individuals in the inpatient and convalescent groups tested positive for autoantibodies. 8:01

Origin of the concept of autoimmunity in COVID-19 and its potential impact on pandemic management.
  • Autoimmunity in COVID-19 first discussed over a year ago, leading to collaborations and research breakthroughs. 8:10

  • Initial skepticism from some experts, but collaborations with researchers like Professor Bruce Uhaul have advanced the concept. 9:55

  • Autoimmunity in COVID-19 has the potential to change pandemic management strategies. 10:21

  • Exploration of autoimmunity in COVID-19 symptoms and implications for future research. 11:00